Speaker illustration

Professor Dipen Shah

Geneva University Hospitals, Geneva (Switzerland)

Member of:

European Heart Rythm Association

Dipen Shah trained as an interventional cardiologist in India, then as an electrophysiology fellow in Bordeaux with Pr Haissaguerre. He spent 6 years in Bordeaux, performing clinical research related to the catheter ablation of atrial flutter, and fibrillation as well as participating in the development of pulmonary vein isolation. He joined the University Hospitals Geneva as a staff electrophysiologist in 2002 and is currently director of the electrophysiology unit. His current interests include catheter ablation and lesion estimation technologies as well as ablation strategies for atypical flutter, persistent AF and analysis of the underlying mechanisms.

Ventricular arrhythmias in different etiologies of non-ischemic CMP and congenital heart disease

Event: EHRA Course on Advanced EP, with focus on VT Ablation

Topic: Ablation of Ventricular Arrhythmias

Session type: Symposium

Thumbnail

Case reports I: An arrhythmia and its ablation - by the faculty

Event: EHRA Course on Advanced EP, with focus on VT Ablation

Topic: Ablation of Ventricular Arrhythmias

Session type: Special Session

Thumbnail

Functional substrate mapping in practice

Event: EHRA Course on Advanced EP, with focus on VT Ablation

Topic: Ablation of Ventricular Arrhythmias

Session type: Symposium

Thumbnail

Industry session

Event: EHRA Course on Advanced EP, with focus on VT Ablation

Topic: Ablation of Ventricular Arrhythmias

Session type: Industry Session

Thumbnail

Ventricular arrhythmia ablation procedural flow I: recommendations from the guidelines

Event: EHRA Course on Advanced EP, with focus on VT Ablation

Topic: Ablation of Ventricular Arrhythmias

Session type: Symposium

Thumbnail

Atrial fibrillation: beyond stroke prevention and rhythm control

Event: ESC Congress 2023

Topic: Atrial Fibrillation (AF)

Session type: Abstract Sessions

Thumbnail

Late-breaking science on atrial fibrillation

Event: ESC Congress 2023

Topic: Treatment

Session type: Late-Breaking Science

Thumbnail

Back to the basics: 20 years of entrainment

Event: EHRA 2023

Topic: Clinical

Session type: Symposium

Thumbnail

State-of-the-art management of patients with challenging VT substrates?

Event: ESC Congress 2022

Topic: Treatment

Session type: Symposium

Thumbnail

Atrial fibrillation: rate or rhythm control

Event: ESC Congress 2022

Topic: Rate Control

Session type: Moderated ePosters

Thumbnail

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb